#VisualAbstract: Pitavastatin reduces cardiovascular event risk among patients with HIV
1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, ...
Tag: major adverse cardiovascular events
Pitavastatin reduces cardiovascular event risk among patients with HIV
1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, ...
Testosterone-replacement therapy noninferior to placebo for preventing cardiovascular events
1. In this randomized controlled trial, in adults with hypogonadism and cardiovascular risk factors, testosterone did not reduce the incidence ...
Bempedoic acid reduces the risk of major adverse cardiovascular events
1. In this randomized controlled trial, bempedoic acid significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients with increased cardiovascular ...